Archives

10
Dec

NIH Awards $350K for Study of Compound That Could ‘Starve’ Pancreatic Tumors

In the Curtis Building laboratories, Drs Jordan Winter, Jonathan Brody and Susan Lanza-Jacoby join forces to disrupt the energy supply of pancreatic cancer cells. Susan Lanza-Jacoby, PhD, has been awarded the National Institutes of Health Cancer Institute grant for her work with Jonathan Brody, PhD, Director of Surgical Research and Co-Director of the Jefferson Pancreas, …

19
May

Clue to Switch of Bladder Cancer from Locally Contained to Invasive Found by Jefferson Scientists

Bladder cancer often becomes aggressive and spreads in patients despite treatment, but now researchers at the Kimmel Cancer Center at Jefferson have identified a protein they believe is involved in pushing tumors to become invasive – and deadly. “We have found that IGF-IR is a critical regulator of motility and invasion of bladder cancer cells, …

19
May

Jefferson Scientists Unlock Secret to Powerful Tumor Suppressor That Can Reverse Cancer Progression

Researchers at the Kimmel Cancer Center at Jefferson have discovered how a powerful tumor suppressor called DACH1 works – a finding that explains why restoring its lost function in cancer cells pushes them to become normal again. In the March 29 online early edition of the Proceedings of the National Academy of Sciences (PNAS), the …